Vital Therapies reported $0 in Debt for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Biomarin Pharmaceutical BMRN:US USD 1.08B 986K
Enanta Pharmaceuticals ENTA:US USD 1.42M 83K
Insmed INSM:US USD 807.82M 491K
Intercept Pharmaceuticals ICPT:US USD 332.31M 381.55M
Omeros OMER:US USD 439.82M 125.46M
Orasure Technologies OSUR:US USD 2.18M 450K
Regulus Therapeutics RGLS:US USD 4.48M 32K
Revance Therapeutics RVNC:US USD 388.28M 7.82M
United Therapeutics UTHR:US USD 800M 0